Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

A Novel Anti-CD20 Monoclonal Antibody for Treating Relapsed Immune Thrombocytopenia

Jia Liu, Han Yao, Jia Liu, Jun Tao, Yimei Feng, Xi Zhang

Blood (2024) 144 (Supplement 1): 5431.

https://doi.org/10.1182/blood-2024-206557

Published: 2024

Journal Articles

Hematopoietic Stem Cell Transplant with Thiotepa-Based Conditioning for Adult T-ALL

Lu Zhao, Yuqing Liu, Ting Chen, Yimei Feng, Han Yao, Lidan Zhu, Jia Liu, Huanfeng Liu, Shichun Gao, Lu Wang, Shuhan Tang, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2024) 144 (Supplement 1): 7192.

https://doi.org/10.1182/blood-2024-205161

Published: 2024

Journal Articles

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Han Yao, Xiaoqi Wang, Ruihao Huang, Yimei Feng, Xiaojuan Deng, Ting Chen, Lidan Zhu, Jia Liu, Yuqing Liu, Lu Zhao, Lu Wang, Cheng Zhang, Peiyan Kong, Li Gao, Lei Gao, Qifa Liu, Xiaohui Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 7122.

https://doi.org/10.1182/blood-2024-206679

Published: 2024

Journal Articles

Efficacy and Safety of Decitabine Combined with FB3 As Conditional Regimen for Elderly/Frail Acute Myeloid Leukemia Patient with Allo-HSCT

Shichun Gao, Lidan Zhu, Jia Liu, Huanfeng Liu, Lu Wang, Peiyan Kong, Cheng Zhang, Li Gao, Ting Chen, Yimei Feng, Yuqing Liu, Han Yao, Lu Zhao, Lei Gao, Xi Zhang

Blood (2024) 144 (Supplement 1): 7317.

https://doi.org/10.1182/blood-2024-207037

Published: 2024

Journal Articles

Serum Tsrna Can be Used As a Biomarker of the Activation States of T Cells for Early Detection of GvHD after Allogeneic Stem Cell Transplantation

Lin Xia, Wei Xu, Shuhan Tang, Han Yao, Lu Zhao, Yuqing Liu, Ting Chen, Jie Tang, Xiaoli Chen, Li Wang, Shijie Yang, Yimei Feng, Xi Zhang

Blood (2024) 144 (Supplement 1): 7107.

https://doi.org/10.1182/blood-2024-204395

Published: 2024

Journal Articles

Protein Language Model-Based Intra-Gene Disparity of Donor HLA Alleles Informs Prognostic Risk in Hematologic Malignancy Patients Undergoing Haplo-Identical HSCT: A Combined Xinqiao-CIBMTR Analysis

Yimei Feng, Yijie Wang, Xiaobo Li, Da Di, Xiangjun Liu, Xi Zhang

Blood (2024) 144 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2024-209297

Published: 2024

Journal Articles

Survival and Risk Prediction Model for Acute Leukemia Patientsundergoing Hematopoietic Stem Cell Transplantation

Xiaoli Chen, Yimei Feng, Jie Tang, Lin Xia, Shanshan Du, Feng Ran, Liquan Jiang, Lei Gao, Xi Zhang

Blood (2024) 144 (Supplement 1): 7450.

https://doi.org/10.1182/blood-2024-207410

Published: 2024

Journal Articles

Sirolimus Combined Dexamethasone As the First-Line Therapy for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Open-Label, Prospective, Randomized Controlled Clinical Trial

Yimei Feng, Hanqing Zeng, Yi Liao, Yi Yang, Wenzheng Yu, Changyong Yuan, Guojun Li, Zhanshu Liu, Huae Shu, Guoxiang Zhang, Yaqing Feng, Chunfang Peng, Xiaoli Chen, Jia Liu, Han Yao, Ming Hou, Xi Zhang

Blood (2024) 144 (Supplement 1): 1187.

https://doi.org/10.1182/blood-2024-207041

Published: 2024

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial

Yimei Feng, Linhui Wang, Tao Lang, Mingqiang Ren, Hai Yi, Jianchuan Deng, Liangliang Ma, Hongyun Xing, Dan Wang, Han Yao, Ting Chen, Yuqing Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2023-188481

Published: 2023

Journal Articles

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

Huanfeng Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lu Wang, Peiyan Kong, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 6967.

https://doi.org/10.1182/blood-2023-188407

Published: 2023

Journal Articles

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Blood (2023) 142 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2023-189104

Published: 2023

Journal Articles

Application Gene Variation Detection before and after Hematopoietic Stem Cell Transplantation to Predict the Relapse of Hematopoietic Neoplasm Patients after Transplantation: Retrospective Data from a Single Center in China

Jia Liu, Peiyan Kong, Lidan Zhu, Shichun Gao, Lu Wang, Huanfeng Liu, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 6975.

https://doi.org/10.1182/blood-2023-188458

Published: 2023

Journal Articles

Efficacy and Safety of Azacytidine Combined with Low-Dose Lenalidomide in Preemptive Treatment of Post Allo-SCT Acute Myeloid Leukemia Patients with Detectable Minimal Residual Disease

Lu Wang, Yimei Feng, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2022) 140 (Supplement 1): 12933.

https://doi.org/10.1182/blood-2022-168641

Published: 2022

Journal Articles

Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium for Steroid-Refractory Chronic Graft-Versus-Host Disease

Ting Chen, Han Yao, Yuqing Liu, Lidan Zhu, Jia Liu, Liu Huanfeng, Shichun Gao, Lu Wang, Lu Zhao, Yimei Feng, Lei Gao, Xi Zhang, Peiyan Kong

Blood (2022) 140 (Supplement 1): 4784–4785.

https://doi.org/10.1182/blood-2022-169673

Published: 2022

Journal Articles

Combination Azacitidine and Lenalidomide: A Novel Relapse Prophylaxis Option in Patients after Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

Yimei Feng, Lu Wang, Ting Chen, Han Yao, Yun Zhang, Yuqing Liu, Lu Zhao, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2022) 140 (Supplement 1): 4894.

https://doi.org/10.1182/blood-2022-169465

Published: 2022

Journal Articles

Activation of SIRT1 Deacetylase As a Therapeutic Approach for Myelodysplastic Syndromes By Restoring TET2 Function

Blood (2017) 130 (Supplement 1): 2497.

https://doi.org/10.1182/blood.V130.Suppl_1.2497.2497

Published: 2017

Journal Articles

TET2 Activity Is Modulated By SIRT1-Mediated Protein Deacetylation: A Potential Therapeutic Target in Myelodysplastic Syndrome

Jie Sun, MS, Yinghui Zhu, PhD, Zonghui Ding, PhD, Haojie Dong, PhD, Yimei Feng, PhD MD, Qiang Chen, PhD, Xiaochun Yu, PhD MD, Dandan Zhao, MD, Herman Wu, BS, Lifeng Feng, PhD, Kaoru Tohyama, MD PhD, Philipp Oberdoerffer, PhD, Bin Zhang, PhD, Ya-Huei Kuo, PhD, Ravi Bhatia, MD, Hongchuan Jin, PhD MD, Guido Marcucci, MD, Ling Li, PhD

Blood (2016) 128 (22): 1053.

https://doi.org/10.1182/blood.V128.22.1053.1053

Published: 2016

NARROW

A Novel Anti-CD20 Monoclonal Antibody for Treating Relapsed Immune Thrombocytopenia

Hematopoietic Stem Cell Transplant with Thiotepa-Based Conditioning for Adult T-ALL

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Efficacy and Safety of Decitabine Combined with FB3 As Conditional Regimen for Elderly/Frail Acute Myeloid Leukemia Patient with Allo-HSCT

Serum Tsrna Can be Used As a Biomarker of the Activation States of T Cells for Early Detection of GvHD after Allogeneic Stem Cell Transplantation

Protein Language Model-Based Intra-Gene Disparity of Donor HLA Alleles Informs Prognostic Risk in Hematologic Malignancy Patients Undergoing Haplo-Identical HSCT: A Combined Xinqiao-CIBMTR Analysis

Survival and Risk Prediction Model for Acute Leukemia Patientsundergoing Hematopoietic Stem Cell Transplantation

Sirolimus Combined Dexamethasone As the First-Line Therapy for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Open-Label, Prospective, Randomized Controlled Clinical Trial

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Application Gene Variation Detection before and after Hematopoietic Stem Cell Transplantation to Predict the Relapse of Hematopoietic Neoplasm Patients after Transplantation: Retrospective Data from a Single Center in China

Efficacy and Safety of Azacytidine Combined with Low-Dose Lenalidomide in Preemptive Treatment of Post Allo-SCT Acute Myeloid Leukemia Patients with Detectable Minimal Residual Disease

Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium for Steroid-Refractory Chronic Graft-Versus-Host Disease

Combination Azacitidine and Lenalidomide: A Novel Relapse Prophylaxis Option in Patients after Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

Activation of SIRT1 Deacetylase As a Therapeutic Approach for Myelodysplastic Syndromes By Restoring TET2 Function

TET2 Activity Is Modulated By SIRT1-Mediated Protein Deacetylation: A Potential Therapeutic Target in Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only